Provides behavioral authentication and threat detection for mobile and web apps to protect against cyber threats.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
BioCatch, Inc. is a United States company, which provides behavioral authentication and threat detection. The Company provides solutions for mobile and Web applications. Available as a cloud-based solution, the Company collects and analyzes more than 400 bio-behavioral, cognitive and physiological parameters to generate a user profile. Its technology helps banking and eCommerce users against cyber threats, such as Account Takeovers, Man-in-the-Browser (MitB) Malware and Remote Access (RAT) attacks. The Company creates a behavioral biometric signature that it associates with the user profile. If deviations are detected, then a real-time alert can be sent to the bank or e-commerce site. BioCatch monitors how users interact with online and mobile applications.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
BioCatch Management Team
Investors
Blumberg International Partners
BioCatch Valuations & Financials
View real-time NPM data on BioCatch stock including daily BioCatch stock price estimates, valuation history, and historical share price information. Access BioCatch financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track BioCatch pricing across six independent market signals. Looking for private company due diligence data sources on BioCatch? Get in touch to learn more.
Similar Companies
like BioCatch
FAQ
We have answers
BioCatch stock does not trade on public stock exchanges. BioCatch stock is considered a private security and you need to be an accredited investor to trade shares. To invest in BioCatch stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
BioCatch Stock does not trade on public stock exchanges. In order to sell BioCatch shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
BioCatch does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view BioCatch share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for BioCatch stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell BioCatch stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in BioCatch stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
BioCatch is a private company and has not had an IPO. There is currently no BioCatch IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to BioCatch IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
